Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.59 |
| ▸ | TERT | O14746 | 3/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 3/20 | 0.49 |
| ▸ | PPARD | Q03181 | 3/20 | 0.49 |
| ▸ | PPARA | Q07869 | 3/20 | 0.49 |
| ▸ | TOP1 | P11387 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | FABP4 | P15090 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | GMNN | O75496 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20262190 | 1.00 | FAAH (0.59) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL20262144 | 0.87 | DGKA (0.55) | FAAHCYP1A2MAPTCYP2C19BLM | |
| SCHEMBL20262145 | 0.87 | DGKA (0.55) | FAAHCYP1A2MAPTCYP2C19BLM | |
| SCHEMBL514368 | 0.86 | FAAH (0.77) | FAAHMAPTNPSR1 | |
| SCHEMBL514366 | 0.86 | FAAH (0.77) | FAAHMAPTNPSR1 | |
| SCHEMBL22981998 | 0.86 | DGKA (0.56) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL8961932 | 0.86 | NAAA (0.55) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL8961986 | 0.86 | NAAA (0.55) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL25228444 | 0.86 | DGKA (0.56) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL8495250 | 0.86 | DGKA (0.56) | FAAHTERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637422-B2 | Ionizable cationic lipid for RNA delivery | ARCTURUS THERAPEUTICS, INC. (US) | 2026-05-26 | — | — | US | disclosed |
| US-20260131020-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-12527881-B2 | Ionizable cationic lipid for RNA delivery | ARCTURUS THERAPEUTICS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| EP-4527831-A2 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | Arcturus Therapeutics, Inc. (US) | 2025-03-26 | — | — | EP | disclosed |
| EP-4310075-A2 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | Arcturus Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-4310075-A2 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | Arcturus Therapeutics, Inc. (US) | 2024-01-24 | — | — | EP | disclosed |
| EP-3558943-B1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS INC (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-3558943-B1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS INC (US) | 2023-10-18 | — | — | EP | disclosed |
| EP-3558942-B1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS INC (US) | 2023-09-06 | — | — | EP | disclosed |
| EP-3558942-B1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS INC (US) | 2023-09-06 | — | — | EP | disclosed |
| WO-2018119163-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | PAYNE JOSEPH E (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018119163-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | PAYNE JOSEPH E (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018118102-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. (US) | 2018-06-28 | — | — | WO | disclosed |
| WO-2018118102-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. (US) | 2018-06-28 | — | — | WO | disclosed |
| US-20180170866-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180170866-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180169268-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180169268-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180170866-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-06-21 | — | — | US | disclosed |
| US-20180169268-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260131020-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | SLC27A1, NSUN3, SLC10A1 | FAAH 1291/4885TERT 1675/4885PTPN1 3322/4885 |
| US-20180170866-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | RNASEH1, RNASE1, HNRNPA1 | FAAH 1465/4885TERT 1965/4885PTPN1 4602/4885 |
| US-20180169268-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | RNASEH1, RNASE1, HNRNPA1 | FAAH 1854/4885TERT 1682/4885PTPN1 4524/4885 |
| US-12637422-B2 | Ionizable cationic lipid for RNA delivery | POLRMT, SLC27A1, SLC43A1 | FAAH 890/4885TERT 1175/4885PTPN1 2544/4885 |
| US-12527881-B2 | Ionizable cationic lipid for RNA delivery | NSUN3, SLC27A1, SLC43A1 | FAAH 1373/4885TERT 2035/4885PTPN1 3663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.